Edition:
United States

Merck & Co Inc (MRK)

MRK on New York Consolidated

79.01USD
13 Dec 2018
Change (% chg)

$1.00 (+1.28%)
Prev Close
$78.01
Open
$78.25
Day's High
$79.08
Day's Low
$78.00
Volume
10,756,280
Avg. Vol
10,569,147
52-wk High
$80.19
52-wk Low
$52.83

Chart for

About

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes... (more)

Overall

Beta: 0.83
Market Cap(Mil.): $176,050.70
Shares Outstanding(Mil.): 2,727.35
Dividend: 0.47
Yield (%): 2.91

Financials

  MRK Industry Sector
P/E (TTM): 35.16 31.13 34.39
EPS (TTM): 1.84 -- --
ROI: 6.58 15.55 14.96
ROE: 12.28 16.92 16.52

McDonald's to curb antibiotic use in its beef supply

McDonald's Corp said on Tuesday it plans to reduce the use of antibiotics in its global beef supply, fueling projections that other restaurants will follow suit.

Dec 11 2018

UPDATE 2-McDonald's to curb antibiotic use in its beef supply

Dec 11 McDonald's Corp said on Tuesday it plans to reduce the use of antibiotics in its global beef supply, fueling projections that other restaurants will follow suit.

Dec 11 2018

BRIEF-Roche Collaborates With Merck To Develop Companion Diagnostic Test To Identify Patients Eligible For Anti-Pd-1 Therapy

* ROCHE TO DEVELOP COMPANION DIAGNOSTIC TEST TO HELP IDENTIFY PATIENTS ELIGIBLE FOR ANTI-PD-1 THERAPY BASED ON BIOMARKER EXPRESSION, NOT LOCATION, OF SOLID TUMORS

Dec 11 2018

Exclusive: Activist investor Elliott has stake in Germany's Bayer - sources

FRANKFURT/NEW YORK Activist investor Elliott has taken a position in Germany's Bayer , adding to the slew of investments the fund has made in German companies, three people familiar with the matter told Reuters on Friday.

Dec 07 2018

UPDATE 3-Bayer to sell businesses, cut jobs after Monsanto deal

* Around 12,000 jobs to go (Adds asset values, potential buyers of animal health unit)

Nov 29 2018

Merck raised prices five drugs including Keytruda in November

NEW YORK Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling cancer treatment Keytruda.

Nov 28 2018

Merck raised prices five drugs including Keytruda in November

NEW YORK, Nov 28 Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling cancer treatment Keytruda.

Nov 28 2018

Bayer looks at options for consumer brands, animal health: sources

FRANKFURT Bayer will discuss selling certain consumer health brands at a supervisory board meeting this week and will also review options for its animal health division, people close to the matter said.

Nov 26 2018

Merck lacks arguments to overturn Fosamax ruling, plaintiffs tell SCOTUS

Some 500 women suing Merck & Co over its osteoporosis drug Fosamax have urged the U.S. Supreme Court to uphold a federal appeals court ruling that allowed their cases to move forward.

Nov 19 2018

Merck drug Keytruda succeeds in late-stage esophageal cancer trial

Merck & Co's blockbuster drug Keytruda met the main goal of a late-stage trial testing the treatment in patients with cancers of the digestive tract, the U.S. drugmaker said on Wednesday.

Nov 14 2018

Earnings vs. Estimates